Health: Cancer Drugs Fund
House of Lords
Lord Walton of Detchant (Crossbench)
To ask Her Majesty’s Government how they will ensure that patients newly diagnosed with cancer after 1 April 2014 will receive appropriate treatment when funding through the Cancer Drugs Fund ends on 31 March.
Earl Howe (Conservative)
In the context of developing new pricing arrangements for branded medicines, we are exploring ways in which new patients can continue to benefit from innovative cancer drugs at a cost that represents value to the National Health Service.